{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:28:45Z","timestamp":1774283325335,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T00:00:00Z","timestamp":1489795200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"the National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2015R1C1A2A01051461"],"award-info":[{"award-number":["NRF-2015R1C1A2A01051461"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00213-017-4598-5","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T08:42:50Z","timestamp":1489826570000},"page":"1923-1932","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Body and liver fat content and adipokines in schizophrenia: a magnetic resonance imaging and spectroscopy study"],"prefix":"10.1007","volume":"234","author":[{"given":"Jong-Hoon","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pil-Whan","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Machann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Roden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheen-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Hee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,18]]},"reference":[{"key":"4598_CR1","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Press, Washington DC","edition":"4"},{"key":"4598_CR2","doi-asserted-by":"crossref","first-page":"12858","DOI":"10.1073\/pnas.1515484112","volume":"112","author":"IL Aye","year":"2015","unstructured":"Aye IL, Rosario FJ, Powell TL, Jansson T (2015) Adiponectin supplementation in pregnant mice prevents the adverse effects of maternal obesity on placental function and fetal growth. Proc Natl Acad Sci U S A 112:12858\u201312863","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4598_CR3","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/070674370204700805","volume":"47","author":"T Baptista","year":"2002","unstructured":"Baptista T, Beaulieu S (2002) Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs? Can J Psychiatr 47:742\u2013749","journal-title":"Can J Psychiatr"},{"key":"4598_CR4","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.euroneuro.2015.06.011","volume":"25","author":"F Bartoli","year":"2015","unstructured":"Bartoli F, Crocamo C, Clerici M, Carr\u00e0 G (2015) Second-generation antipsychotics and adiponectin levels in schizophrenia: a comparative meta-analysis. Eur Neuropsychopharmacol 25:1767\u20131774","journal-title":"Eur Neuropsychopharmacol"},{"key":"4598_CR5","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.ejrad.2016.02.013","volume":"85","author":"T Baum","year":"2016","unstructured":"Baum T, Cordes C, Dieckmeyer M, Ruschke S, Franz D, Hauner H, Kirschke JS, Karampinos DC (2016) MR-based assessment of body fat distribution and characteristics. Eur J Radiol 85:1512\u20131518","journal-title":"Eur J Radiol"},{"key":"4598_CR6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/JCP.0b013e318166c4f7","volume":"28","author":"AB Birkenaes","year":"2008","unstructured":"Birkenaes AB, Birkeland KI, Engh JA, Faerden A, Jonsdottir H, Ringen PA, Friis S, Opjordsmoen S, Andreassen OA (2008) Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions. J Clin Psychopharmacol 28:132\u2013137","journal-title":"J Clin Psychopharmacol"},{"key":"4598_CR7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00330-010-1905-5","volume":"21","author":"AE Bohte","year":"2011","unstructured":"Bohte AE, van Werven JR, Bipat S, Stoker J (2011) The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 21:87\u201397","journal-title":"Eur Radiol"},{"key":"4598_CR8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/oby.2010.296","volume":"19","author":"MA Bredella","year":"2011","unstructured":"Bredella MA, Torriani M, Ghomi RH, Thomas BJ, Brick DJ, Gerweck AV, Harrington LM, Miller KK (2011) Adiponectin is inversely associated with intramyocellular and intrahepatic lipids in obese premenopausal women. Obesity (Silver Spring) 19:911\u2013916","journal-title":"Obesity (Silver Spring)"},{"key":"4598_CR9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1463-1326.2005.00543.x","volume":"8","author":"DC Chan","year":"2006","unstructured":"Chan DC, Watts GF, Ng TW, Hua J, Song S, Barrett PH (2006) Measurement of liver fat by magnetic resonance imaging: relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men. Diabetes Obes Metab 8:698\u2013702","journal-title":"Diabetes Obes Metab"},{"key":"4598_CR10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.schres.2007.10.003","volume":"98","author":"J Leon de","year":"2008","unstructured":"de Leon J, Correa JC, Ruano G, Windemuth A, Arranz MJ, Diaz FJ (2008) Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels. Schizophr Res 98:40\u201346","journal-title":"Schizophr Res"},{"key":"4598_CR11","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1073\/pnas.0904944106","volume":"106","author":"E Fabbrini","year":"2009","unstructured":"Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, Okunade A, Klein S (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 106:15430\u201315435","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4598_CR12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1192\/bjp.bp.108.052605","volume":"194","author":"E Fernandez-Egea","year":"2009","unstructured":"Fernandez-Egea E, Bernardo M, Donner T, Conget I, Parellada E, Justicia A, Esmatjes E, Garcia-Rizo C, Kirkpatrick B (2009) Metabolic profile of antipsychotic-naive individuals with non-affective psychosis. Br J Psychiatry 194:434\u2013438","journal-title":"Br J Psychiatry"},{"key":"4598_CR13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2337\/diacare.27.3.739","volume":"27","author":"JM Fern\u00e1ndez-Real","year":"2004","unstructured":"Fern\u00e1ndez-Real JM, Castro A, V\u00e1zquez G, Casamitjana R, L\u00f3pez-Bermejo A, Pe\u00f1arroja G, Ricart W (2004) Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes Care 27:739\u2013745","journal-title":"Diabetes Care"},{"key":"4598_CR14","volume-title":"Structured clinical interview for DSM-IV axis I disorders research version (SCID-I)","author":"MB First","year":"1996","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW (1996) Structured clinical interview for DSM-IV axis I disorders research version (SCID-I). New York State Psychiatric Institute Biometrics Research, New York"},{"key":"4598_CR15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","volume":"116","author":"CS Fox","year":"2007","unstructured":"Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D\u2019Agostino RB Sr, O\u2019Donnell CJ (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39\u201348","journal-title":"Circulation"},{"key":"4598_CR16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/B978-0-12-800101-1.00009-0","volume":"121","author":"Y Fu","year":"2014","unstructured":"Fu Y (2014) Adiponectin signaling and metabolic syndrome. Prog Mol Biol Transl Sci 121:293\u2013319","journal-title":"Prog Mol Biol Transl Sci"},{"key":"4598_CR17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.clnu.2004.04.010","volume":"23","author":"M Gil-Campos","year":"2004","unstructured":"Gil-Campos M, Ca\u00f1ete RR, Gil A (2004) Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 23:963\u2013974","journal-title":"Clin Nutr"},{"key":"4598_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2014.11.008","volume":"25","author":"P Goncalves","year":"2015","unstructured":"Goncalves P, Araujo JR, Martel F (2015) Antipsychotics-induced metabolic alterations: focus on adipose tissue and molecular mechanisms. Eur Neuropsychopharmacol 25:1\u201316","journal-title":"Eur Neuropsychopharmacol"},{"key":"4598_CR19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.schres.2008.09.008","volume":"106","author":"L Hanssens","year":"2008","unstructured":"Hanssens L, van Winkel R, Wampers M, Van Eyck D, Scheen A, Reginster JY, Collette J, Peuskens J, De Hert M (2008) A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder. Schizophr Res 106:308\u2013314","journal-title":"Schizophr Res"},{"key":"4598_CR20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S2215-0366(15)00115-7","volume":"2","author":"DC Henderson","year":"2015","unstructured":"Henderson DC, Vincenzi B, Andrea NV, Ulloa M, Copeland PM (2015) Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. Lancet Psychiatry 2:452\u2013464","journal-title":"Lancet Psychiatry"},{"key":"4598_CR21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0269881105056647","volume":"20","author":"H Hosojima","year":"2006","unstructured":"Hosojima H, Togo T, Odawara T, Hasegawa K, Miura S, Kato Y, Kanai A, Kase A, Uchikado H, Hirayasu Y (2006) Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia. J Psychopharmacol 20:75\u201379","journal-title":"J Psychopharmacol"},{"key":"4598_CR22","doi-asserted-by":"crossref","first-page":"E1663","DOI":"10.1152\/ajpendo.00590.2006","volume":"293","author":"JH Hwang","year":"2007","unstructured":"Hwang JH, Stein DT, Barzilai N, Cui MH, Tonelli J, Kishore P, Hawkins M (2007) Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab 293:E1663\u2013E1669","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4598_CR23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.schres.2007.11.026","volume":"100","author":"H Jin","year":"2008","unstructured":"Jin H, Meyer JM, Mudaliar S, Jeste DV (2008) Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin. Schizophr Res 100:70\u201385","journal-title":"Schizophr Res"},{"key":"4598_CR24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276","journal-title":"Schizophr Bull"},{"key":"4598_CR25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1639-8","volume":"207","author":"SL Kirk","year":"2009","unstructured":"Kirk SL, Glazebrook J, Grayson B, Neill JC, Reynolds GP (2009) Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors. Psychopharmacology 207:119\u2013125","journal-title":"Psychopharmacology"},{"key":"4598_CR26","doi-asserted-by":"crossref","first-page":"592","DOI":"10.5551\/jat.7625","volume":"18","author":"K Kishida","year":"2011","unstructured":"Kishida K, Kim KK, Funahashi T, Matsuzawa Y, Kang HC, Shimomura I (2011) Relationships between circulating adiponectin levels and fat distribution in obese subjects. J Atheroscler Thromb 18:592\u2013595","journal-title":"J Atheroscler Thromb"},{"key":"4598_CR27","doi-asserted-by":"crossref","first-page":"16180","DOI":"10.1523\/JNEUROSCI.3202-10.2010","volume":"30","author":"C Koch","year":"2010","unstructured":"Koch C, Augustine RA, Steger J, Ganjam GK, Benzler J, Pracht C, Lowe C, Schwartz MW, Shepherd PR, Anderson GM, Grattan DR, Tups A (2010) Leptin rapidly improves glucose homeostasis in obese mice by increasing hypothalamic insulin sensitivity. J Neurosci 30:16180\u201316187","journal-title":"J Neurosci"},{"key":"4598_CR28","first-page":"937","volume":"18","author":"A Kotronen","year":"2010","unstructured":"Kotronen A, Seppanen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, Ruskeepaa AL, Yki-Jarvinen H, Oresic M (2010) Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum. Obesity(Silver Spring) 18:937\u2013944","journal-title":"Obesity(Silver Spring)"},{"key":"4598_CR29","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1161\/01.CIR.0000127953.98131.ED","volume":"109","author":"M Kumada","year":"2004","unstructured":"Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K, Maeda K, Nagaretani H, Kishida K, Maeda N, Nagasawa A, Funahashi T, Matsuzawa Y (2004) Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 109:2046\u20132049","journal-title":"Circulation"},{"key":"4598_CR30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/met.2011.0123","volume":"10","author":"M Lilja","year":"2012","unstructured":"Lilja M, Rolandsson O, Norberg M, S\u00f6derberg S (2012) The impact of leptin and adiponectin on incident type 2 diabetes is modified by sex and insulin resistance. Metab Syndr Relat Disord 10:143\u2013151","journal-title":"Metab Syndr Relat Disord"},{"key":"4598_CR31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10334-013-0421-4","volume":"27","author":"RS Livingstone","year":"2014","unstructured":"Livingstone RS, Begovatz P, Kahl S, Nowotny B, Strassburger K, Giani G, Bunke J, Roden M, Hwang JH (2014) Initial clinical application of modified Dixon with flexible echo times: hepatic and pancreatic fat assessments in comparison with (1)H MRS. MAGMA 27:397\u2013405","journal-title":"MAGMA"},{"key":"4598_CR32","doi-asserted-by":"crossref","unstructured":"Lu ML, Wang TN, Lin TY, Shao WC, Chang SH, Chou JY, Ho YF, Liao YT, Chen VC (2015 ) Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin. Prog Neuropsychopharmacol Biol Psychiatry: 47\u201350","DOI":"10.1016\/j.pnpbp.2014.12.001"},{"key":"4598_CR33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1148\/radiol.10092284","volume":"257","author":"J Machann","year":"2010","unstructured":"Machann J, Thamer C, Stefan N, Schwenzer NF, Kantartzis K, Haring HU, Claussen CD, Fritsche A, Schick F (2010) Follow-up whole-body assessment of adipose tissue compartments during a lifestyle intervention in a large cohort at increased risk for type 2 diabetes. Radiology 257:353\u2013363","journal-title":"Radiology"},{"key":"4598_CR34","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1096\/fj.07-098095","volume":"22","author":"B Mattioli","year":"2008","unstructured":"Mattioli B, Straface E, Matarrese P, Quaranta MG, Giordani L, Malorni W, Viora M (2008) Leptin as an immunological adjuvant: enhanced migratory and CD8+ T cell stimulatory capacity of human dendritic cells exposed to leptin. FASEB J 22:2012\u20132022","journal-title":"FASEB J"},{"key":"4598_CR35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4088\/JCP.v63n0509","volume":"63","author":"JM Meyer","year":"2002","unstructured":"Meyer JM (2002) A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year. J Clin Psychiatry 63:425\u2013433","journal-title":"J Clin Psychiatry"},{"key":"4598_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2004.01.014","volume":"70","author":"JM Meyer","year":"2004","unstructured":"Meyer JM, Koro CE (2004) The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr Res 70:1\u201317","journal-title":"Schizophr Res"},{"key":"4598_CR37","doi-asserted-by":"crossref","first-page":"E1247","DOI":"10.1152\/ajpendo.00274.2009","volume":"297","author":"DL Morris","year":"2009","unstructured":"Morris DL, Rui L (2009) Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 297:E1247\u2013E1259","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4598_CR38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1440-1819.2007.01610.x","volume":"61","author":"M Murashita","year":"2007","unstructured":"Murashita M, Inoue T, Kusumi I, Nakagawa S, Itoh K, Tanaka T, Izumi T, Hosoda H, Kangawa K, Koyama T (2007) Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia. Psychiatry Clin Neurosci 61:54\u201358","journal-title":"Psychiatry Clin Neurosci"},{"key":"4598_CR39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.psyneuen.2004.05.008","volume":"30","author":"M Murashita","year":"2005","unstructured":"Murashita M, Kusumi I, Inoue T, Takahashi Y, Hosoda H, Kangawa K, Koyama T (2005) Olanzapine increases plasma ghrelin level in patients with schizophrenia. Psychoneuroendocrinology 30:106\u2013110","journal-title":"Psychoneuroendocrinology"},{"key":"4598_CR40","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.physiol.70.113006.100707","volume":"70","author":"MG Myers","year":"2008","unstructured":"Myers MG, Cowley MA, M\u00fcnzberg H (2008) Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 70:537\u2013556","journal-title":"Annu Rev Physiol"},{"key":"4598_CR41","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00394-014-0748-2","volume":"54","author":"J Neamat-Allah","year":"2015","unstructured":"Neamat-Allah J, Johnson T, Nabers D, H\u00fcsing A, Teucher B, Katzke V, Delorme S, Kaaks R, K\u00fchn T (2015) Can the use of blood-based biomarkers in addition to anthropometric indices substantially improve the prediction of visceral fat volume as measured by magnetic resonance imaging? Eur J Nutr 54:701\u2013708","journal-title":"Eur J Nutr"},{"key":"4598_CR42","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/2012.jama.11132","volume":"308","author":"IJ Neeland","year":"2012","unstructured":"Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, Grundy SM, Khera A, McGuire DK, de Lemos JA (2012) Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 308:1150\u20131159","journal-title":"JAMA"},{"key":"4598_CR43","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jacc.2003.10.049","volume":"43","author":"K Ohashi","year":"2004","unstructured":"Ohashi K, Ouchi N, Kihara S, Funahashi T, Nakamura T, Sumitsuji S, Kawamoto T, Matsumoto S, Nagaretani H, Kumada M, Okamoto Y, Nishizawa H, Kishida K, Maeda N, Hiraoka H, Iwashima Y, Ishikawa K, Ohishi M, Katsuya T, Rakugi H, Ogihara T, Matsuzawa Y (2004) Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol 43:1195\u20131200","journal-title":"J Am Coll Cardiol"},{"key":"4598_CR44","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1017\/S1461145714000157","volume":"17","author":"RM Paredes","year":"2014","unstructured":"Paredes RM, Quinones M, Marballi K, Gao X, Valdez C, Ahuja SS, Velligan D, Walss-Bass C (2014) Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome. Int J Neuropsychopharmacol 17:1139\u20131148","journal-title":"Int J Neuropsychopharmacol"},{"key":"4598_CR45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.jcp.0000218404.64619.52","volume":"26","author":"AA Richards","year":"2006","unstructured":"Richards AA, Hickman IJ, Wang AY, Jones AL, Newell F, Mowry BJ, Whitehead JP, Prins JB, Macdonald GA (2006) Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: a potential mechanism for olanzapine-induced insulin resistance in patients with schizophrenia. J Clin Psychopharmacol 26:232\u2013237","journal-title":"J Clin Psychopharmacol"},{"key":"4598_CR46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S1461145711001271","volume":"15","author":"S Skrede","year":"2012","unstructured":"Skrede S, Ferno J, Vazquez MJ, Fjaer S, Pavlin T, Lunder N, Vidal-Puig A, Dieguez C, Berge RK, Lopez M, Steen VM (2012) Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats. Int J Neuropsychopharmacol 15:163\u2013179","journal-title":"Int J Neuropsychopharmacol"},{"key":"4598_CR47","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/01.chi.0000170552.15798.dd","volume":"44","author":"AL Sporn","year":"2005","unstructured":"Sporn AL, Bobb AJ, Gogtay N, Stevens H, Greenstein DK, Clasen LS, Tossell JW, Nugent T, Gochman PA, Sharp WS, Mattai A, Lenane MC, Yanovski JA, Rapoport JL (2005) Hormonal correlates of clozapine-induced weight gain in psychotic children: an exploratory study. J Am Acad Child Adolesc Psychiatry 44:925\u2013933","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"4598_CR48","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/oby.2003.48","volume":"11","author":"H Staiger","year":"2003","unstructured":"Staiger H, Tschritter O, Machann J, Thamer C, Fritsche A, Maerker E, Schick F, H\u00e4ring HU, Stumvoll M (2003) Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res 11:368\u2013372","journal-title":"Obes Res"},{"key":"4598_CR49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eurpsy.2009.01.001","volume":"24","author":"FC Starrenburg","year":"2009","unstructured":"Starrenburg FC, Bogers JP (2009) How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins. Eur Psychiatry 24:164\u2013170","journal-title":"Eur Psychiatry"},{"key":"4598_CR50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1037\/0033-2909.87.2.245","volume":"87","author":"JH Steiger","year":"1980","unstructured":"Steiger JH (1980) Tests for comparing elements of a correlation matrix. Psychol Bull 87:245\u2013251","journal-title":"Psychol Bull"},{"key":"4598_CR51","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.psyneuen.2015.09.026","volume":"63","author":"B Stubbs","year":"2016","unstructured":"Stubbs B, Wang AK, Vancampfort D, Miller BJ (2016) Are leptin levels increased among people with schizophrenia versus controls? A systematic review and comparative meta-analysis. Psychoneuroendocrinology 63:144\u2013154","journal-title":"Psychoneuroendocrinology"},{"key":"4598_CR52","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/JCP.0b013e3182524393","volume":"32","author":"T Sugai","year":"2012","unstructured":"Sugai T, Suzuki Y, Fukui N, Ono S, Watanabe J, Tsuneyama N, Someya T (2012) Dysregulation of adipocytokines related to second-generation antipsychotics in normal fasting glucose patients with schizophrenia. J Clin Psychopharmacol 32:390\u2013393","journal-title":"J Clin Psychopharmacol"},{"key":"4598_CR53","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.ijo.0801220","volume":"24","author":"E Tai","year":"2000","unstructured":"Tai E, Lau TN, Ho SC, Fok AC, Tan CE (2000) Body fat distribution and cardiovascular risk in normal weight women. Associations with insulin resistance, lipids and plasma leptin. Int J Obes Relat Metab Disord 24:751\u2013757","journal-title":"Int J Obes Relat Metab Disord"},{"key":"4598_CR54","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.dsx.2015.04.009","volume":"9","author":"DA Tanyanskiy","year":"2015","unstructured":"Tanyanskiy DA, Martynikhin IA, Rotar OP, Konradi AO, Sokolian NA, Neznanov NG, Denisenko AD (2015) Association of adipokines with metabolic disorders in patients with schizophrenia: results of comparative study with mental healthy cohort. Diabetes Metab Syndr 9:163\u2013167","journal-title":"Diabetes Metab Syndr"},{"key":"4598_CR55","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1017\/S0954422412000054","volume":"25","author":"EL Thomas","year":"2012","unstructured":"Thomas EL, Frost G, Taylor-Robinson SD, Bell JD (2012a) Excess body fat in obese and normal-weight subjects. Nutr Res Rev 25:150\u2013161","journal-title":"Nutr Res Rev"},{"key":"4598_CR56","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/oby.2011.142","volume":"20","author":"EL Thomas","year":"2012","unstructured":"Thomas EL, Parkinson JR, Frost GS, Goldstone AP, Dor\u00e9 CJ, McCarthy JP, Collins AL, Fitzpatrick JA, Durighel G, Taylor-Robinson SD, Bell JD (2012b) The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat. Obesity (Silver Spring) 20:76\u201387","journal-title":"Obesity (Silver Spring)"},{"key":"4598_CR57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00004850-200401000-00007","volume":"19","author":"T Togo","year":"2004","unstructured":"Togo T, Kojima K, Shoji M, Kase A, Uchikado H, Katsuse O, Iseki E, Kosaka K (2004) Serum adiponectin concentrations during treatment with olanzapine or risperidone: a pilot study. Int Clin Psychopharmacol 19:37\u201340","journal-title":"Int Clin Psychopharmacol"},{"key":"4598_CR58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.euroneuro.2011.03.010","volume":"22","author":"M Wampers","year":"2012","unstructured":"Wampers M, Hanssens L, van Winkel R, Heald A, Collette J, Peuskens J, Reginster JY, Scheen A, De Hert M (2012) Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study. Eur Neuropsychopharmacol 22:17\u201326","journal-title":"Eur Neuropsychopharmacol"},{"key":"4598_CR59","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00228-015-1807-1","volume":"71","author":"Z Whitney","year":"2015","unstructured":"Whitney Z, Procyshyn RM, Fredrikson DH, Barr AM (2015) Treatment of clozapine-associated weight gain: a systematic review. Eur J Clin Pharmacol 71:389\u2013401","journal-title":"Eur J Clin Pharmacol"},{"issue":"11 Suppl 1","key":"4598_CR60","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1210\/jc.2008-1630","volume":"93","author":"SC Woods","year":"2008","unstructured":"Woods SC, D\u2019Alessio DA (2008) Central control of body weight and appetite. J Clin Endocrinol Metab 93(11 Suppl 1):S37\u2013S50","journal-title":"J Clin Endocrinol Metab"},{"key":"4598_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-013-3193-7","volume":"229","author":"H Yan","year":"2013","unstructured":"Yan H, Chen JD, Zheng XY (2013) Potential mechanisms of atypical antipsychotic-induced hypertriglyceridemia. Psychopharmacology 229:1\u20137","journal-title":"Psychopharmacology"},{"key":"4598_CR62","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1161\/CIRCRESAHA.107.156596","volume":"101","author":"R Yang","year":"2007","unstructured":"Yang R, Barouch LA (2007) Leptin signaling and obesity: cardiovascular consequences. Circ Res 101:545\u2013559","journal-title":"Circ Res"},{"key":"4598_CR63","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1192\/bjp.184.1.58","volume":"184","author":"ZJ Zhang","year":"2004","unstructured":"Zhang ZJ, Yao ZJ, Liu W, Fang Q, Reynolds GP (2004) Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia. Br J Psychiatry 184:58\u201362","journal-title":"Br J Psychiatry"},{"key":"4598_CR64","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0022-3956(03)00018-9","volume":"37","author":"U Zimmermann","year":"2003","unstructured":"Zimmermann U, Kraus T, Himmerich H, Schuld A, Pollmacher T (2003) Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res 37:193\u2013220","journal-title":"J Psychiatr Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-017-4598-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4598-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4598-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T18:43:56Z","timestamp":1568918636000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-017-4598-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,18]]},"references-count":64,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["4598"],"URL":"https:\/\/doi.org\/10.1007\/s00213-017-4598-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,18]]}}}